Stocktoria
RECURSION PHARMACEUTICALS, INC. RXRX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-04-16
Chart by TradingView
3/9
Piotroski F — financial health
-1.13
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $74.7M | $58.8M | $44.6M | $39.8M | $10.2M |
| Operating income | -$648.1M | -$479.0M | -$350.1M | -$245.7M | -$182.8M |
| Net income | -$644.8M | -$463.7M | -$328.1M | -$239.5M | -$186.5M |
| Operating cash flow | -$371.8M | -$359.2M | -$287.8M | -$83.5M | -$158.6M |
| Free cash flow | -$378.3M | -$372.9M | -$299.7M | -$120.6M | -$198.4M |
| Total assets | $1.5B | $1.4B | $653.7M | $701.3M | $610.3M |
| Total liabilities | $343.3M | $413.8M | $190.3M | $215.5M | $67.4M |
| Shareholders' equity | $1.1B | $1.0B | $463.4M | $485.8M | $542.9M |
| Ratios | |||||
| Operating margin | -867.9% | -814.1% | -785.3% | -616.7% | -1795.8% |
| Net margin | -863.4% | -788.0% | -736.0% | -601.0% | -1832.2% |
| FCF margin | -506.5% | -633.7% | -672.4% | -302.6% | -1949.4% |
| Return on assets | -43.7% | -32.0% | -50.2% | -34.1% | -30.6% |
| Return on equity | -57.0% | -44.8% | -70.8% | -49.3% | -34.3% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | 5.50 | 3.81 | 4.70 | 5.68 | 11.46 |
| Revenue growth | 26.9% | 32.0% | 11.9% | 291.5% | 156.9% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| ARK Investment Management LLC | 40,212,769 | $123.5M |
| RENAISSANCE TECHNOLOGIES LLC | 2,400,605 | $7.4M |
| Point72 Asset Management, L.P. | 46,300 | $142,141 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.13 (distress)
- Working capital / assets 0.451
- Retained earnings / assets -1.408
- EBIT / assets -0.44
- Equity / liabilities 3.294
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001601830 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.